New software tool provides a way for safer design of genome editing

A team of researchers has developed a software tool called DANGER (Deleterious and ANticipatable Guides Evaluated by RNA-sequencing) analysis that provides a way for the safer design of genome editing in all organisms with a transcriptome.

UZH researchers harness AI to detect antibiotic resistance

Researchers at the University of Zurich (UZH) have used artificial intelligence (AI) to help identify antibiotic-resistant bacteria.

October 17, 2024

IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up

HOUSTON — Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to

November 25, 2024

Turn Bio and HanAll to develop therapies for age-related conditions

The companies will jointly develop therapies for age-related eye and ear ailments. Credit: Yurii_Yarema / Shutterstock.com. Turn Biotechnologies (Turn Bio) has entered an exclusive worldwide

May 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.